The position of the u.s. pharmcopeia on risk-based microbial testing of cell therapies

Publication date: May 2021Source: Cytotherapy, Volume 23, Issue 5, SupplementAuthor(s): T. Cundell

Source: Cytotherapy - May 12, 2021 Category: Cytology Source Type: research